Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To describe the development and progression of neuropathy and related findings among patients with type 1 diabetes who participated in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. RESEARCH DESIGN AND METHODS: The main diabetic peripheral neuropathy (DPN) outcome was assessed using clinical symptoms, signs, and nerve conduction study results during DCCT and repeated in EDIC year 13/14. Cardiovascular autonomic neuropathy (CAN) was assessed by R-R response to paced breathing, Valsalva ratio, and blood pressure response to standing during DCCT and in EDIC years 13/14 and 16/17. Additionally, symptoms reflecting neuropathic pain and autonomic function (including hypoglycemia awareness) were collected yearly in EDIC using standardized questionnaires; peripheral neuropathy was also assessed annually using the Michigan Neuropathy Screening Instrument. Assessments of genitourinary function were collected at EDIC year 10. RESULTS: Intensive therapy during the DCCT significantly reduced the risk of DPN and CAN at DCCT closeout (64% and 45%, respectively, P < 0.01). The prevalence and incidence of DPN and CAN remained significantly lower in the DCCT intensive therapy group compared with the DCCT conventional therapy group through EDIC year 13/14. CONCLUSIONS: The persistent effects of prior intensive therapy on neuropathy measures through 14 years of EDIC largely mirror those observed for other diabetes complications. DCCT/EDIC provides important information on the influence of glycemic control, and the clinical course of diabetic neuropathy, and, most important, on how to prevent neuropathy in type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A combination of typical symptomatology and symmetrical distal sensory loss, or typical signs in the absence of symptoms, in a person with DM is highly suggestive of DPN and may not require additional evaluations or referral.547,565–567”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [565]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The diagnosis of DPN is principally a clinical one.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [565]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The Diabetes Control and Complications Trial (DCCT) and its observational follow-up study, Epidemiology of Diabetes Interventions and Complications (EDIC), conclusively demonstrated that intensive glucose control applied early in the course of type 1 diabetes (T1D), significantly reduces the risk of developing CAN [2–4].”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Electrophysiological testing or referral to a neurologist is rarely needed for diagnosis, except in situations where the clinical features are atypical, the diagnosis is unclear, and a different etiology is suspected.547,554,565”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [565]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566 · cited 1×
“Painful symptoms are frequently refractory to treatment, and loss of protective sensation heightens the risk for foot ulceration and lowerextremity amputations (19,20).”
BackgroundVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,293
Spallone, V., Ziegler, D., Freeman, R., Bernardi, L., Frontoni, S., Pop‐Busui, R., Stevens, M., Kempler, P., Hilsted, J., Tesfaye, S., et al. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1239 · Cited by 957
Self-citationEffect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Maser, R. E., Mitchell, B. D., Vinik, A. I., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1895 · Cited by 578 · cited 1×
“Yet, CAN is an independent predictor of mortality (21,22), possibly by promoting life-threatening arrhythmias and sudden death in response to a variety of insults including drug side effects, hypoglycemia, hypokalemia, hypotension, or ischemia (23).”
BackgroundPop-Busui, R., Evans, G. W., Gerstein, H. C., Fonseca, V., Fleg, J. L., Hoogwerf, B. J., Genuth, S., Grimm, R. H., Corson, M. A., Prineas, R., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0125 · Cited by 540 · cited 1×
“Yet, CAN is an independent predictor of mortality (21,22), possibly by promoting life-threatening arrhythmias and sudden death in response to a variety of insults including drug side effects, hypoglycemia, hypokalemia, hypotension, or ischemia (23).”
BackgroundSelf-citationHerman, W. H., Pop‐Busui, R., Braffett, B. H., Martin, C. L., Cleary, P. A., Albers, J. W., Feldman, E. L., & The DCCT/EDIC Research Group (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03644.x · Cited by 493
Self-citationMaser, R. E., Steenkiste, A. R., Dorman, J. S., Nielsen, V. K., Bass, E. B., Manjoo, Q., Drash, A. L., Becker, D. J., Kuller, L. H., Greene, D. A., et al. (1989) · Diabetes · doi:10.2337/diab.38.11.1456 · Cited by 408
Albers, J. W., Herman, W. H., Pop-Busui, R., Feldman, E. L., Martin, C. L., Cleary, P. A., Waberski, B. H., Lachin, J. M., & for the DCCT/EDIC Research Group (2010) · Diabetes Care · doi:10.2337/dc09-1941 · Cited by 401
Self-citationNeuropathy among the diabetes control and complications trial cohort 8 years after trial completion
Martin, C. L., Albers, J., Herman, W. H., Cleary, P., Waberski, B., Greene, D. A., Stevens, M. J., & Feldman, E. L. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1549 · Cited by 350
Self-citationPop-Busui, R., Low, P. A., Waberski, B. H., Martin, C. L., Albers, J. W., Feldman, E. L., Sommer, C., Cleary, P. A., Lachin, J. M., & Herman, W. H. (2009) · Circulation · doi:10.1161/circulationaha.108.837369 · Cited by 310
Self-citationNot Available, N. A. (1998) · Diabetologia · doi:10.1007/s001250050924 · Cited by 308
DCCT Research Group, B. N. (1995) · Annals of Neurology · doi:10.1002/ana.410380607 · Cited by 283
Relation of Glycemic Control to Diabetic Microvascular Complications in Diabetes Mellitus
Klein, R., Klein, B. E. K., & Moss, S. E. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-1_part_2-199601011-00003 · Cited by 279 · cited 1×
“In the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) (26), DPN was assessed by tactile or temperature sensitivity; and they reported abnormalities in 19–25% and 11–19% of participants, respectively, after 10 years of follow-up.”
BackgroundPop‐Busui, R., Herman, W. H., Feldman, E. L., Low, P. A., Martin, C. L., Cleary, P. A., Waberski, B. H., Lachin, J. M., & Albers, J. W. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0120-8 · Cited by 129
Self-citationSacre, J. W., Franjic, B., Jellis, C. L., Jenkins, C., Coombes, J. S., & Marwick, T. H. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2010.09.014 · Cited by 123 · cited 1×
“Although these crosssectional findings prevent analysis of any causal relationship between CAN and ventricular dysfunction, other studies have demonstrated a relationship between sympathetic activation and left ventricular hypertrophy (29,30).”
BackgroundWhat Do We Know and We Do Not Know About Cardiovascular Autonomic Neuropathy in Diabetes
Pop‐Busui, R. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9367-6 · Cited by 114 · cited 1×
“Yet, CAN is an independent predictor of mortality (21,22), possibly by promoting life-threatening arrhythmias and sudden death in response to a variety of insults including drug side effects, hypoglycemia, hypokalemia, hypotension, or ischemia (23).”
BackgroundSelf-citationEffect of Intensive Glycemic Therapy on Erectile Function in Men With Type 1 Diabetes
Wessells, H., Penson, D. F., Cleary, P. A., Rutledge, B. N., Lachin, J. M., McVary, K. T., Schade, D. S., & Sarma, A. V. (2011) · The Journal of Urology · doi:10.1016/j.juro.2010.12.098 · Cited by 92
Martin, C. L., Waberski, B. H., Pop‐Busui, R., Cleary, P. A., Catton, S., Albers, J. W., Feldman, E. L., & Herman, W. H. (2010) · Diabetes Care · doi:10.2337/dc10-0616 · Cited by 90
Self-citationAssociation Between Cardiovascular Autonomic Neuropathy and Left Ventricular Dysfunction
Pop-Busui, R., Cleary, P. A., Braffett, B. H., Martin, C. L., Herman, W. H., Low, P. A., Lima, J. A. C., & Bluemke, D. A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.028 · Cited by 88
Self-citationEeden, S. K. V. D., Sarma, A. V., Rutledge, B. N., Cleary, P. A., Kusek, J. W., Nyberg, L. M., McVary, K. T., & Wessells, H. (2009) · Diabetes Care · doi:10.2337/dc07-2375 · Cited by 68
Albers, J. W., Herman, W. H., Pop‐Busui, R., Martin, C. L., Cleary, P. A., & Waberski, B. H. (2007) · Diabetes Care · doi:10.2337/dc07-0850 · Cited by 59
Self-citationSarma, A. V., Kanaya, A. M., Nyberg, L. M., Kusek, J. W., Vittinghoff, E., Rutledge, B. N., Cleary, P. A., Gatcomb, P., & Brown, J. S. (2009) · Urology · doi:10.1016/j.urology.2008.11.009 · Cited by 52
Urinary Incontinence Among Women With Type 1 Diabetes—How Common is it?
Sarma, A. V., Kanaya, A. M., Nyberg, L. M., Kusek, J. W., Vittinghoff, E., Rutledge, B. N., Cleary, P. A., Gatcomb, P., & Brown, J. S. (2009) · The Journal of Urology · doi:10.1016/j.juro.2008.11.024 · Cited by 38
Yang, C. C., Porter, M. P., & Penson, D. F. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06246.x · Cited by 22
Cited by
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
“The highly reproducible and sensitive testing protocol, the robust definitions used for CAN, and the large sample size in DCCT/EDIC enhance the validity of the results and support the rationale for implementing and maintaining tight glucose control as early as possible in the course of type 1 diabetes.”
BackgroundMethodInfluentialSelf-citationNathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Feldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0092-1 · Cited by 1,697
Self-citationNew Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.005 · Cited by 915
Differentiation of diabetes by pathophysiology, natural history, and prognosis
Skyler, J. S., Bakris, G. L., Bonifacio, E., Darsow, T., Eckel, R. H., Groop, L., Groop, P.-H., Handelsman, Y., Insel, R. A., Mathieu, C., et al. (2017) · Diabetes · doi:10.2337/db16-0806 · Cited by 823
Metadata
- Authors
- Martin, C. L., Albers, J. W., Pop-Busui, R., & for the DCCT/EDIC Research Group
- Affiliations
- University of Michigan (US)
- Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan Medical School, Ann Arbor, MI
- Corresponding author
- Martin, Catherine L.
- ORCID
- Martin, Catherine L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-12-11
- Volume
- 37
- Issue
- 1
- Pages
- 31-38
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3868000
- OpenAlex
- W2115038969
- Cited by
- 499
- References
- 30
- Citations by year
- 2026: 25 · 2025: 27 · 2024: 45 · 2023: 38 · 2022: 40 · 2021: 57 · 2020: 50 · 2019: 41 · 2018: 45 · 2017: 28 · 2016: 34 · 2015: 42 · 2014: 23 · 2013: 4
- FWCI
- 27.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Sanofi
- BD
- Roche Diabetes Care
- National Institutes of Health (UL1TR000041, UL1TR000114, 5u01dk094157-13, UL1TR001449)
- Abbott Diabetes Care
- National Eye Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK094176, U01-DK094157, P30DK020572)
- National Institute of Neurological Disorders and Stroke
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, cardiac autonomic neuropathy, type 1 diabetes, tight glycemic control, neuropathy progression, neuropathic pain, hypoglycemia awareness, genitourinary function, Michigan Neuropathy Screening Instrument, DCCT/EDIC, neuropathy prevention
- MeSH terms
- Adolescent, Adult, Aged, Blood Glucose, Blood Pressure, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Dose-Response Relationship, Drug, Female, Glycated Hemoglobin, Humans, Insulin, Male, Middle Aged, Neural Conduction, Peripheral Nervous System Diseases, Risk Factors, Incidence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.